Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow ALGN
Align Technology, Inc. (ALGN) Return on equity
Align Technology, Inc.'s return on equity over the twelve months to 30 June 2026 was 10.2%, down 0.2 percentage points from fiscal 2025 (10.4%). Over the past ten years it has ranged from 10.0% (fiscal 2022) to 77.6% (fiscal 2020); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of −1.32% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 10.4% | (0.87) |
| FY2024 | 11.3% | (1.05) |
| FY2023 | 12.3% | 2.30 |
| FY2022 | 10.0% | (12.51) |
| FY2021 | 22.5% | (55.03) |
| FY2020 | 77.6% | 43.48 |
| FY2019 | 34.1% | 0.82 |
| FY2018 | 33.3% | 11.72 |
| FY2017 | 21.5% | 0.95 |
| FY2016 | 20.6% | 2.59 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| SOLV Solventum Corporation compare | 34.0% |
| ATR AptarGroup, Inc. compare | 13.5% |
| ALGN Align Technology, Inc. | 10.2% |
| COO The Cooper Companies, Inc. compare | 6.84% |
| RGEN Repligen Corporation compare | 1.99% |
| BLCO Bausch + Lomb Corporation compare | −2.64% |
| AVTR Avantor, Inc. compare | −9.70% |
| BAX Baxter International Inc. compare | −15.8% |
| TFX Teleflex Incorporated compare | −28.9% |
| Medical Instruments & Supplies industry median | −1.32% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement